Cardlytics (CDLX) Tops Q3 EPS by 21c

Cardlytics (NASDAQ: CDLX) reported Q3 EPS of ($0.33), $0.21 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $65 million versus the consensus estimate of $62.08 million.

GUIDANCE:

Cardlytics sees FY2021 revenue of $247-257 million, versus the consensus of $253 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Solstice acquiring Element Solutions in $14.5B cash and stock deal
• S&P Global releases recast financials after Mobility spin-off
• Middleby completes spin-off of food processing unit as Midera